Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Revenue

Marksans Pharma had revenue of 7.54B INR in the quarter ending December 31, 2025, with 10.64% growth. This brings the company's revenue in the last twelve months to 28.03B, up 13.29% year-over-year. In the fiscal year ending March 31, 2025, Marksans Pharma had annual revenue of 26.23B with 20.46% growth.

• Revenue (ttm): 28.03B
• Revenue Growth: +13.29%
• P/S Ratio: 2.93
• Revenue / Employee: 15.24M
• Employees: 1,840
• Market Cap: 82.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	26.23B	4.45B	20.46%
Mar 31, 2024	21.77B	3.25B	17.56%
Mar 31, 2023	18.52B	3.61B	24.23%
Mar 31, 2022	14.91B	1.15B	8.33%
Mar 31, 2021	13.76B	2.42B	21.32%